These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27387917)

  • 1. The Boehringer Ingelheim employee study (Part 2): 10-year cardiovascular diseases risk estimation.
    Kempf K; Martin S; Döhring C; Dugi K; Haastert B; Schneider M
    Occup Med (Lond); 2016 Oct; 66(7):543-550. PubMed ID: 27387917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Framingham Risk Score and Estimated 10-Year Cardiovascular Disease Risk Reduction by a Short-Term Yoga-Based LifeStyle Intervention.
    Yadav R; Yadav RK; Sarvottam K; Netam R
    J Altern Complement Med; 2017 Sep; 23(9):730-737. PubMed ID: 28437144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Reed ML; Kurth T; Fanning KM; Buse DC
    Headache; 2017 Nov; 57(10):1507-1521. PubMed ID: 28990165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiological Boehringer Ingelheim Employee study--part I: impact of overweight and obesity on cardiometabolic risk.
    Kempf K; Martin S; Döhring C; Dugi K; Wolfram von Wolmar C; Haastert B; Schneider M
    J Obes; 2013; 2013():159123. PubMed ID: 23997947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of FRAMINGHAM, PROCAM and SCORE models in Turkish people with Type 2 diabetes: comparison of three cardiovascular risk calculations.
    Bayındır Çevik A; Özcan Ş; Satman İ
    Contemp Nurse; 2015; 50(2-3):183-95. PubMed ID: 26503421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of cardiovascular disease risk factors and the Framingham Risk Score in patients undergoing percutaneous intervention over the last 17 years by gender: time-trend analysis from the Mayo Clinic PCI Registry.
    Lee MS; Flammer AJ; Kim HS; Hong JY; Li J; Lennon RJ; Lerman A
    J Prev Med Public Health; 2014 Jul; 47(4):216-29. PubMed ID: 25139168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).
    Pease A; Earnest A; Ranasinha S; Nanayakkara N; Liew D; Wischer N; Andrikopoulos S; Zoungas S
    Cardiovasc Diabetol; 2018 Jun; 17(1):77. PubMed ID: 29859534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome.
    Jahangiry L; Farhangi MA; Rezaei F
    J Health Popul Nutr; 2017 Nov; 36(1):36. PubMed ID: 29132438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic progression is associated with increased cardiovascular risk in patients with axial spondyloarthritis.
    Kang KY; Her YH; Ju JH; Hong YS; Park SH
    Mod Rheumatol; 2016 Jul; 26(4):601-6. PubMed ID: 26565692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22).
    Zhang XL; Wan G; Yuan MX; Yang GR; Fu HJ; Zhu LX; Xie RR; Lv YJ; Zhang JD; Li YL; Dai QF; Ji Y; Holman RR; Yuan SY;
    Diabetes Ther; 2020 Apr; 11(4):885-903. PubMed ID: 32086768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic alterations predictive of cardiovascular disease risk in the Québec population.
    Scarsella C; Alméras N; Mauriège P; Blanchet C; Sauvé L; Dewailly E; Bergeron J; Després JP
    Can J Cardiol; 2003 Jan; 19(1):51-7. PubMed ID: 12571695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Alternative Healthy Eating Index as a predictor of 10-year cardiovascular disease risk in a group of Iranian employees.
    Hariri N; Darafshi Ghahroudi S; Nasseri E; Bondarianzadeh D; Houshyar-Rad A; Zayeri F
    J Hum Nutr Diet; 2017 Aug; 30(4):499-505. PubMed ID: 27726209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations.
    Gaziano TA; Abrahams-Gessel S; Alam S; Alam D; Ali M; Bloomfield G; Carrillo-Larco RM; Dorairaj P; Gutierrez L; Irazola V; Levitt NS; Miranda JJ; Bernabe-Ortiz A; Pandya A; Rubinstein A; Steyn K; Xavier D; Yan LL
    Glob Heart; 2016 Mar; 11(1):37-46.e2. PubMed ID: 27102021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicted 10-year risk of cardiovascular disease among Canadian adults using modified Framingham Risk Score in association with dietary intake.
    Setayeshgar S; Whiting SJ; Pahwa P; Vatanparast H
    Appl Physiol Nutr Metab; 2015 Oct; 40(10):1068-74. PubMed ID: 26417841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.